Holmes Biopharma, Inc. (LMB) Earnings
|
Expand Research on LMB
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +67.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +12.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/15/18 |  |
Q118 | -$0.60 | $0.05 | -$0.65 | $120.5M | $120.33M | = |  | | Details |
| 11/14/19 | |
Q319 | -$0.44 | $0.20 | -$0.64 | $147.8M | $142.5M | = | | | Details |
| 11/19/18 | |
Q318 | -$0.46 | N/A | N/A | $135.06M | $140.77M | = | | | Details |
| 5/8/24 | Q124 | N/A | $0.42 | N/A | N/A | $132M | = | N/A | N/A | ||
3/17/22  |
|
Q421 | N/A | $0.40 | N/A | N/A | $128.57M | = | N/A | N/A | |
| 11/14/17 | |
Q317 | -$0.12 | N/A | N/A | $121.3M | $91.89M | = | | | Details |
| 8/14/19 | |
Q219 | -$0.20 | $0.19 | -$0.39 | $132.8M | $138M | = | | | Details |
| 4/2/18 |
|
Q417 | N/A | $0.39 | N/A | N/A | $118M | = | N/A | N/A |
